Correction to: Vedolizumab Concentrations Are Associated with Long-Term Endoscopic Remission in Patients with Inflammatory Bowel Diseases. Dig Dis Sci 2019 Dec;64(12):3674-3675
Date
10/24/2019Pubmed ID
31642007DOI
10.1007/s10620-019-05876-0Scopus ID
2-s2.0-85074053317 (requires institutional sign-in at Scopus site)Abstract
The original version of the article unfortunately contained a couple of errors. In 'methods' section, in 'Outcomes' subsection, the sentence 'Endoscopic remission was defined as an SESCD ≤ 2 in patients with CD and an EMS ≤ 2 in UC patients while off corticosteroids.'